New low-dose chemo combo after transplant aims to stop leukemia relapse
Disease control
Recruiting now
This study tests whether a milder chemotherapy combination (decitabine and venetoclax) given weekly after a bone marrow transplant can help prevent relapse in people with high-risk acute myeloid leukemia or related blood cancers. About 20 participants will receive the treatment f…
Phase: PHASE1, PHASE2 • Sponsor: Benjamin Tomlinson • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC